Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,067 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,373
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +14.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (618)

clinicaltrialsPublishedShowing 451–452 of 452 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00034333	Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer	terminated	Phase 2 / Phase 3	240	FeRxINDUSTRY	8	Jun 24, 2005	clinicaltrials
NCT00057382	T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients	terminated	Phase 2 / Phase 3	750	TularikINDUSTRY	11	Jun 24, 2005	clinicaltrials